AboutMed Plant Science | Psychedelic Biotechnology Company
Med Plant Science is a biotechnology company leading research, development, and clinical trials using active compounds from psychedelic plants and fungi alongside compassionate therapy to end conventional maintenance of conditions and relieve afflictions affectively and expeditiously. MPS is on track to begin the first clinical trials of rapid onset medication using Nano-encapsulation technology in Canada in 2022.
Med Plant Science was founded to improve patient mental health with psychedelic ingredient breakthroughs alongside traditional therapy. MPS intends to help patients thrive where other conventional symptom management treatments and medication have fallen short.
Med Plant Science is headquartered in Calgary and operating and licensed to grow, process, extract, and export psychedelic compounds on the Island of Saint Vincent in the Caribbean.
Med Plant Science is proud to announce the acquisition of a license from the island of Saint Vincent and the Grenadines to grow, process, extract, and export psychedelic compounds from plants and mushrooms.